Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06334055 · ClinicalTrials.gov registry record · NA
Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT06334055 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 101 participants.
The verdict
NCT06334055, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
The aim of the study is to validate the Mean Arterial Pressure (MAP) parameter of Masimo INVSENSOR00073 against the gold standard blood pressure measurements from the arterial line while subject undergo a blood pressure variation procedure.
Interventions
- DEVICE Masimo INVSENSOR00073
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2024-03-04 |
| Est. Completion | 2024-11-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06334055
The ClinicalTrials.gov registry entry for NCT06334055 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Masimo INVSENSOR00073 is the first listed.
NCT06334055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06334055 about?
NCT06334055 is a clinical study titled "Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073". The aim of the study is to validate the Mean Arterial Pressure (MAP) parameter of Masimo INVSENSOR00073 against the gold standard blood pressure measurements from the arterial line while subject undergo a blood pressure variation procedure.
What is the current status of trial NCT06334055?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2024-03-04. Estimated completion is 2024-11-08.
What interventions are being tested in trial NCT06334055?
The interventions under investigation include: Masimo INVSENSOR00073 (DEVICE).
Who is sponsoring clinical trial NCT06334055?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.